A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

NCT00735085 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

57

Enrollment

INDUSTRY

Sponsor class

Stopped This study was stopped 20 May 2010 due to strategic considerations

Conditions

Traumatic Brain Injury

Interventions

DRUG: SLV334
DRUG: SLV334
DRUG: SLV334
DRUG: SLV334
DRUG: Placebo

Sponsor

Abbott Products

Collaborators

[object Object]